Metric Finance
LearnFAQ
LearnFAQ

Learn / TNDM

NASDAQ: TNDM

Tandem Diabetes Care (TNDM) stock, explained like you're 5

Tandem Diabetes Care trades on the Nasdaq under the ticker TNDM. It is a small cap company in the medical/dental instruments industry, part of the healthcare sector, with a market value of about 1.1 billion dollars.

Ticker
TNDM
Exchange
Nasdaq
Sector
Healthcare
Industry
Medical/Dental Instruments
Size
Small cap, about 1.1 billion dollars

Is Tandem Diabetes Care a small, medium or large cap company?

No. Tandem Diabetes Care is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 1.1 billion dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Tandem Diabetes Care makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves TNDM stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • Should App Recall Require Action From Tandem Diabetes Care Stock Investors? (Simply Wall Street)
  • Why Did TNDM Stock Jump 5% After Hours Despite Q4 Earnings Miss? (Stocktwits)
  • Is it the Right Time to Hold TNDM Stock in Your Portfolio? (Yahoo Finance)
  • Mizuho cuts target for Tandem Diabetes Care stock from USD 20.00 to USD 18.00 (ad-hoc-news.de)
  • An insulin delivery company will hold a results call Nov. 5 at 4:30 p.m. ET. (Stock Titan)

Follow TNDM in your daily brief

Each trading day at 5 PM ET we post what happened to Tandem Diabetes Care and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow TNDM

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Tandem Diabetes Care stock

What does Tandem Diabetes Care do?

Tandem Diabetes Care trades on the Nasdaq under the ticker TNDM. It is a small cap company in the medical/dental instruments industry, part of the healthcare sector, with a market value of about 1.1 billion dollars.

What is the ticker symbol for Tandem Diabetes Care?

Tandem Diabetes Care trades under the ticker TNDM on the Nasdaq.

What is Tandem Diabetes Care's market cap?

Tandem Diabetes Care is a small cap stock with a market cap of about 1.1 billion dollars.

How does Tandem Diabetes Care make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves TNDM stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow TNDM stock every day?

Add TNDM to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow TNDM daily

A free brief on Tandem Diabetes Care and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • SYK · Stryker
  • BDX · Becton Dickinson & co
  • MDLN · Medline
  • RMD · Resmed

Similar stocks

  • SYKStryker
  • BDXBecton Dickinson & co
  • MDLNMedline
  • RMDResmed

Compare TNDM: TNDM vs SYK, TNDM vs BDX, TNDM vs MDLN

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed